38 /100
MEDIUM RISK
Score updated May 30, 2026

NBY — NovaBay Pharmaceuticals Inc Dilution Risk Tracker

Track NBY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NBY — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
100
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
13%
💰 Capital Raise 18%
• Active ATM program with $100M remaining capacity
📉 Score Deterioration 15%
• Score climbed 6 points (worsening)
🔔 Track NBY — Get forecast alerts →

💹 Market Data

Market Cap$51.92M
Shares Outstanding26.63M
Float2.62M
Cash$7.96M
Debt$776.0K
Short InterestN/A

🏛 Institutional Holdings

26 institutional holders · 6.34M shares
#1 BlackRock, Inc. 1.83M shares
#2 VANGUARD GROUP INC 1.83M shares
#3 GEODE CAPITAL MANAGEMENT, LLC 1.26M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest647.1K
Days to Cover1.0
% of Float24.7%
FINRA data as of Mar 31, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Apr 09, 2026
4 INSIDER TRANSACTION Apr 08, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NBY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NBY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NBY
📊 NBY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NBY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.